craft-sa-dev Home  

PMC:1448208 / 39452-39826 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T21291 0-2 IN denotes In
T21293 3-10 NN denotes summary
T21294 10-12 , denotes ,
T21295 12-16 DT denotes this
T21296 17-23 NN denotes report
T21292 24-33 VBZ denotes describes
T21297 34-37 DT denotes the
T21298 38-49 NN denotes development
T21299 50-53 CC denotes and
T21300 54-70 NN denotes characterization
T21301 71-73 IN denotes of
T21302 74-85 RB denotes genetically
T21303 86-96 VBN denotes engineered
T21305 97-102 NN denotes mouse
T21304 103-109 NNS denotes models
T21306 110-112 IN denotes of
T21307 113-120 JJ denotes classic
T21309 121-123 RB denotes as
T21311 124-128 RB denotes well
T21310 129-131 IN denotes as
T21312 132-144 JJ denotes intermediate
T21308 145-149 NN denotes MSUD
T21313 149-150 . denotes .
T21314 150-374 sentence denotes These animals provide useful models to further characterize the pathogenesis of MSUD, as well as models to test novel therapeutic strategies, such as gene and cellular therapies, to treat this devastating metabolic disease.
T21315 151-156 DT denotes These
T21316 157-164 NNS denotes animals
T21317 165-172 VBP denotes provide
T21318 173-179 JJ denotes useful
T21319 180-186 NNS denotes models
T21320 187-189 TO denotes to
T21322 190-197 RB denotes further
T21321 198-210 VB denotes characterize
T21323 211-214 DT denotes the
T21324 215-227 NN denotes pathogenesis
T21325 228-230 IN denotes of
T21326 231-235 NN denotes MSUD
T21327 235-237 , denotes ,
T21328 237-239 RB denotes as
T21330 240-244 RB denotes well
T21329 245-247 IN denotes as
T21331 248-254 NNS denotes models
T21332 255-257 TO denotes to
T21333 258-262 VB denotes test
T21334 263-268 JJ denotes novel
T21336 269-280 JJ denotes therapeutic
T21335 281-291 NNS denotes strategies
T21337 291-293 , denotes ,
T21338 293-297 JJ denotes such
T21339 298-300 IN denotes as
T21340 301-305 NN denotes gene
T21342 306-309 CC denotes and
T21343 310-318 JJ denotes cellular
T21341 319-328 NNS denotes therapies
T21344 328-330 , denotes ,
T21345 330-332 TO denotes to
T21346 333-338 VB denotes treat
T21347 339-343 DT denotes this
T21349 344-355 VBG denotes devastating
T21350 356-365 JJ denotes metabolic
T21348 366-373 NN denotes disease
T21351 373-374 . denotes .
R6204 T21291 T21292 prep In,describes
R6205 T21293 T21291 pobj summary,In
R6206 T21294 T21292 punct ", ",describes
R6207 T21295 T21296 det this,report
R6208 T21296 T21292 nsubj report,describes
R6209 T21297 T21298 det the,development
R6210 T21298 T21292 dobj development,describes
R6211 T21299 T21298 cc and,development
R6212 T21300 T21298 conj characterization,development
R6213 T21301 T21298 prep of,development
R6214 T21302 T21303 advmod genetically,engineered
R6215 T21303 T21304 amod engineered,models
R6216 T21304 T21301 pobj models,of
R6217 T21305 T21304 compound mouse,models
R6218 T21306 T21304 prep of,models
R6219 T21307 T21308 amod classic,MSUD
R6220 T21308 T21306 pobj MSUD,of
R6221 T21309 T21310 advmod as,as
R6222 T21310 T21307 cc as,classic
R6223 T21311 T21310 advmod well,as
R6224 T21312 T21307 conj intermediate,classic
R6225 T21313 T21292 punct .,describes
R6226 T21315 T21316 det These,animals
R6227 T21316 T21317 nsubj animals,provide
R6228 T21318 T21319 amod useful,models
R6229 T21319 T21317 dobj models,provide
R6230 T21320 T21321 aux to,characterize
R6231 T21321 T21319 advcl characterize,models
R6232 T21322 T21321 advmod further,characterize
R6233 T21323 T21324 det the,pathogenesis
R6234 T21324 T21321 dobj pathogenesis,characterize
R6235 T21325 T21324 prep of,pathogenesis
R6236 T21326 T21325 pobj MSUD,of
R6237 T21327 T21317 punct ", ",provide
R6238 T21328 T21329 advmod as,as
R6239 T21329 T21317 cc as,provide
R6240 T21330 T21329 advmod well,as
R6241 T21331 T21317 conj models,provide
R6242 T21332 T21333 aux to,test
R6243 T21333 T21331 advcl test,models
R6244 T21334 T21335 amod novel,strategies
R6245 T21335 T21333 dobj strategies,test
R6246 T21336 T21335 amod therapeutic,strategies
R6247 T21337 T21335 punct ", ",strategies
R6248 T21338 T21339 amod such,as
R6249 T21339 T21335 prep as,strategies
R6250 T21340 T21341 nmod gene,therapies
R6251 T21341 T21339 pobj therapies,as
R6252 T21342 T21340 cc and,gene
R6253 T21343 T21340 conj cellular,gene
R6254 T21344 T21333 punct ", ",test
R6255 T21345 T21346 aux to,treat
R6256 T21346 T21333 advcl treat,test
R6257 T21347 T21348 det this,disease
R6258 T21348 T21346 dobj disease,treat
R6259 T21349 T21348 amod devastating,disease
R6260 T21350 T21348 amod metabolic,disease
R6261 T21351 T21317 punct .,provide